Alpha-Stim
Select Your Language
2201 Garrett Morris Parkway © Copyright 2010 Electromedical Products International, Inc. Alpha-Stim® is registered in the US Patent and Trademark office and worldwide. 
  
|
Celebrating 29 Years 1981-2010 Research Abstracts
Smith, Ray B. Is microcurrent stimulation effective in pain management? An additional perspective. American Journal of Pain Management, 11(2):62-66, 2001.
This is a peer-reviewed analysis of 2,500 consecutive survey forms from warranty cards completed by patients who were prescribed Alpha-Stim microcurrent electrical therapy (MET) and cranial electrotherapy stimulation (CES). The only inclusion criteria were that the patients used their Alpha-Stim for at least 3 weeks. 1,949, or 78% of the total listed pain as their primary diagnosis. Of those, 93% claimed significant pain reduction of greater than 25% improvement, ranging from a low of 82% in chronic regional pain syndrome (RSD) to a high of 98% in those suffering from migraine headaches and 100% in carpal tunnel syndrome. 72% of the patients were female. The age ranged from 15 to 92 years with a mean of 50 years. The length of use ranged from the 3 week minimum cutoff period to 5 years in 2 cases. The average period of use was 14.68 weeks, or just over 3 1/2 months. The results reported by these patients were only 2% off a previous physician survey of 500 patients (the patients self-reports giving slightly higher ratings overall) reported in the book, The Science behind Cranial Electrotherapy Stimulation by Dr. Daniel L. Kirsch.
Return to Research and Reviews |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
